Sarepta drug protects lab monkeys from Ebola

Your Health Matters

By Sharon Begley NEW YORK (Reuters) – An experimental Ebola drug from Sarepta Therapeutics Inc protected six of eight lab monkeys injected with the virus, scientists from the company and the U.S. Army reported on Tuesday. The drug, called AVI-7537, joins ZMapp from Mapp Biopharmaceutical and a compound from Tekmira Pharmaceuticals Corp as the agents shown to cure non-human primates given otherwise-lethal injections of Ebola virus. The ZMapp and Tekmira drugs protected 100 percent of lab monkeys in studies, giving them a possible edge.
Go to Source

facebookShare on Facebook
TwitterTweet
FollowFollow us
PinterestSave